source
- STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and moreWeight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to endSTAT · 1mo ago↗ source
- Neumora depression drug fails; EnGene to cut 50% of staffNeumora’s stumble is the latest setback for a once-promising class of brain drugs. Elsewhere, a cell therapy manufacturing specialist took steps toward an IPO and J&J made its latest U.S investment.BioPharma Dive · 1mo ago↗ source
- How supplement use changed over decadesMedicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning RoundsSTAT · 1mo ago